CDSCO sets rejection deadline for pending drug applications
→Drug applicants must clear CDSCO queries or lose filings and fees
Change
CDSCO set a 30-day rejection deadline for long-pending SUGAM drug applications that have already received three query-response reminders.
Why it matters
Pending drug applications now move to rejection once CDSCO's reminder cycle is exhausted. The mechanism covers Global Clinical Trial, Bioavailability/Bioequivalence, Ethics Committee, and Veterinary divisions. Non-response ends the filing and forfeits the fee, forcing applicants to restart through a fresh application.
Implications
- → Regulatory affairs teams with GCT, BABE, Ethics Committee, or Veterinary applications already through CDSCO's three-reminder cycle must clear pending SUGAM queries by the 30-day cutoff — non-response triggers rejection and fee forfeiture.
- → Clinical trial sponsors and contract research organisations managing CDSCO filings must keep SUGAM query-response ownership current — missed reminders now move inactive applications into final disposal.
- → Generic drug and biosimilar regulatory teams with BA/BE filings must prioritise pending query responses — rejection forfeits the fee and forces a fresh application.
Unlock the full brief.
Implications — what this change may force you to review
Who is affected — which people, workflows, or obligations are touched
What to watch — dates, deadlines, and triggers that matter next
Real-time alerts — delivered when a decision-forcing change is published
Clarify with AI — ask what this change means for you
Start free trial
No credit card · $29/month after trial · Active in seconds
Source
View on CDSCO